Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rheumatic diseases and pregnancy: a perspective.

R C Kitridou1

  • 1LAC/USC Medical Center 90033.

Clinical and Experimental Rheumatology
|April 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus.

Arthritis and rheumatism·1998
Same author

Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus.

The Journal of clinical investigation·1997
Same author

Surgical procedures in the management of Takayasu's arteritis.

Journal of vascular surgery·1990
Same author

Pregnancy in mixed connective tissue disease, poly/dermatomyositis and scleroderma.

Clinical and experimental rheumatology·1988
Same author

Chondritis in systemic lupus erythematosus: clinical and immunopathologic studies.

Clinical and experimental rheumatology·1987
Same author

Anticardiolipin antibodies in unselected autoimmune rheumatic disease patients.

Clinical immunology and immunopathology·1987

Rheumatic disease activity during pregnancy varies due to hormonal changes. Managing these conditions requires considering effects on both mother and fetus from the disease and treatments.

Area of Science:

  • Rheumatology
  • Endocrinology
  • Obstetrics

Background:

  • Rheumatic diseases can exhibit unpredictable behavior during pregnancy.
  • Hormonal fluctuations, particularly involving sex hormones, are implicated in disease course variability.
  • Pregnancy presents unique challenges for managing chronic inflammatory conditions.

Purpose of the Study:

  • To explore the relationship between rheumatic diseases, sex hormones, and pregnancy outcomes.
  • To highlight key considerations for maternal and fetal health in pregnant patients with rheumatic diseases.
  • To review the impact of maternal drug therapy during pregnancy.

Main Methods:

  • Review of existing literature on rheumatic diseases in pregnancy.
  • Analysis of hormonal influences on autoimmune and inflammatory processes.

Related Experiment Videos

  • Case study considerations for drug efficacy and safety.

    • Main Results:

    • Sex hormone fluctuations significantly influence the course of rheumatic diseases during gestation.
    • Disease activity, pregnancy status, and therapeutic interventions all impact maternal and fetal well-being.
    • Careful management is essential to mitigate risks associated with rheumatic diseases in pregnancy.

    Conclusions:

    • The interplay of rheumatic conditions and hormonal shifts necessitates individualized pregnancy management.
    • Comprehensive assessment of maternal disease, fetal development, and drug safety is crucial.
    • Further research is warranted to optimize treatment strategies for rheumatic diseases throughout pregnancy and postpartum.